Medicus Pharma Ltd. (MDCX)
0.26
-0.01
(-4.34%)
USD |
NASDAQ |
Aug 24, 16:00
0.256
0.00 (0.00%)
After-Hours: 20:00
Medicus Pharma Shareholders Equity (Quarterly) : -1.243M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.243M |
| March 31, 2026 | 0.9502M |
| December 31, 2025 | -0.0493M |
| September 30, 2025 | -0.6541M |
| June 30, 2025 | 2.381M |
| March 31, 2025 | 2.148M |
| December 31, 2024 | 2.180M |
| September 30, 2024 | 2.585M |
| Date | Value |
|---|---|
| June 30, 2024 | 4.715M |
| March 31, 2024 | -0.4509M |
| December 31, 2023 | 1.111M |
| September 30, 2023 | 3.507M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -9.003M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 614.86M |
| enGene Therapeutics, Inc. | 255.17M |
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 1.242B |
| Psyence Biomedical Ltd. | 11.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.11M |
| Total Liabilities (Quarterly) | 20.33M |
| Debt to Equity Ratio | -12.27 |
| Current Ratio | 1.566 |
| Net Debt Paydown Yield | -11.14% |